Innate immune receptor C5aR1 regulates cancer cell fate and can be targeted to improve radiotherapy in tumours with immunosuppressive microenvironments (2023)
Attributed to:
Novel strategies to improve the effectiveness of radiation and targeted therapies in lung cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.01.10.521547
Publication URI: http://dx.doi.org/10.1101/2023.01.10.521547
Type: Preprint